Induced Methylation of the KITLG as a Treatment for Hippocampal Degeneration in Bipolar Disorder

Simple item page
dc.contributor.advisorMalatesta, Rebecca
dc.contributor.authorArndt, Brendan
dc.date.accessioned2023-01-09T19:16:40Z
dc.date.available2023-01-09T19:16:40Z
dc.description.abstractThis article is an examination of the literature regarding bipolar disorder and our understanding of it. Specifically, a focus is placed on the biological symptoms associated with bipolar disorder and their impact on the hippocampus. Through this research, a new genetic component will be introduced as a link between bipolar disorder and hippocampal degeneration. It appears that methylation of a specific ligand that mediates the stress response can be used as a treatment for the neurotoxic effects of cortisol. By reducing the high levels of cortisol found in those with bipolar disorder, brain damage to the hippocampus may be reduced. This treatment could be performed through induced methylation of the proposed ligand.en_US
dc.identifier.urihttp://hdl.handle.net/10323/12029
dc.subjectBipolar Disorderen_US
dc.subjectCortisolen_US
dc.subjectGene Methylationen_US
dc.subjectHippocampusen_US
dc.subjectKITLGen_US
dc.titleInduced Methylation of the KITLG as a Treatment for Hippocampal Degeneration in Bipolar Disorderen_US
dc.typeThesiseng

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Arndt Brendan Thesis Final.docx.pdf
Size:
111.24 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.41 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Honors College Theses